| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/17/2011 | CA2770018A1 Novel peptide and use thereof |
| 02/17/2011 | CA2768965A1 Use of il-15 to increase thymic output and to treat lymphopenia |
| 02/17/2011 | CA2765265A1 Method for repairing neurodegeneration |
| 02/16/2011 | EP2284268A2 Conserved HBV and HCV sequences useful for gene silencing |
| 02/16/2011 | EP2284191A2 Process for the preparation of hGH |
| 02/16/2011 | EP2284190A2 Transfer factor from birds eggs |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284187A2 Process for the purification of antithrombin-III |
| 02/16/2011 | EP2284186A1 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
| 02/16/2011 | EP2284180A2 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 02/16/2011 | EP2284179A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation |
| 02/16/2011 | EP2284178A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283860A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/16/2011 | EP2283856A1 Stabilised solid compositions of factor VII polypeptides |
| 02/16/2011 | EP2283855A2 Polypeptides et polynucleotides de phorphorymonas gingivalis |
| 02/16/2011 | EP2283854A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283853A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283852A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283851A2 Compositions and methods for promoting hemostasis and other physiological activities |
| 02/16/2011 | EP2283850A1 Pharmaceutical compositions and methods for peptide treatment |
| 02/16/2011 | EP2283849A1 Preparation of type a2 botulinum neurotoxin |
| 02/16/2011 | EP2283848A1 Equine system for non-surgical articificial insemination |
| 02/16/2011 | EP2283842A1 Tamper-resitant oral opioid agonist formulations |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283820A1 Residual solvent extraction method and microparticles produced thereby |
| 02/16/2011 | EP2283815A1 Propellant-free non polar buccal spray of a sedative |
| 02/16/2011 | EP2283814A1 Polar buccal spray of a sedative |
| 02/16/2011 | EP2283813A1 Propellant-free polar buccal spray of a sedative |
| 02/16/2011 | EP2283809A1 Microneedle array using porous substrate and process for producing same |
| 02/16/2011 | EP2283130A1 DISPERSINBtm, 5-FLUOROURACIL, DEOXYRIBONUCLEASE I AND PROTEINASE K-BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 02/16/2011 | EP2283128A2 Process for the preparation of dipeptides from cyanophycin employing the isolated pseudomonas alcaligenes dip1 cgpase cpheal |
| 02/16/2011 | EP2283033A1 Antiviral cell penetrating peptides |
| 02/16/2011 | EP2283029A1 Peptides |
| 02/16/2011 | EP2282767A2 Site-directed modification of factor ix |
| 02/16/2011 | EP2282766A1 Suture line administration technique using botulinum toxins |
| 02/16/2011 | EP2282765A1 Thrombin derived peptides for smooth muscle relaxation |
| 02/16/2011 | EP2282764A1 Liver-specific nucleic acid regulatory elements and methods and use thereof |
| 02/16/2011 | EP2282763A2 Compositions useful for the treatment of diabetes and other chronic disorders |
| 02/16/2011 | EP2282762A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/16/2011 | EP2282761A2 Inhibition of scarring using tgf-beta 3 |
| 02/16/2011 | EP2282760A1 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 02/16/2011 | EP2282759A2 Use of nucleic acids with reduced pressure therapy for treating wounds |
| 02/16/2011 | EP2282758A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
| 02/16/2011 | EP2282757A1 Neutralization of gm-csf for the treatment of heart failure |
| 02/16/2011 | EP2282755A1 Inhibition of angiogenesis |
| 02/16/2011 | EP2282754A2 Method of treating peripheral arterial disease |
| 02/16/2011 | EP2282753A1 Assay for pathogenic conformers |
| 02/16/2011 | EP2282750A2 Extract with high amount of bioactive components, and its use |
| 02/16/2011 | EP2282725A1 Nasal formulations of insulin |
| 02/16/2011 | EP1931696B1 Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection |
| 02/16/2011 | EP1902719B1 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthracis and its use for anthrax prevention and treatiment |
| 02/16/2011 | EP1877435B1 Glucagon-like-peptide-2 (glp-2) analogues |
| 02/16/2011 | EP1850863B1 Use of botulinum toxin for prolonged local desensitization |
| 02/16/2011 | EP1694356B1 Regulation of food preference using glp-1 agonists |
| 02/16/2011 | EP1469077B1 Cell-specific expression/replication vector |
| 02/16/2011 | EP1466178B1 Screening methods for superoxide dismutase (sod)-inhibitors |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | EP1222265B1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 02/16/2011 | CN1993139B Stabilized interferon liquid formulations |
| 02/16/2011 | CN101977931A Polypeptide and pharmaceutical composition containing the polypeptide |
| 02/16/2011 | CN101977926A Mutant forms of streptolysin o |
| 02/16/2011 | CN101977631A Polymer conjugate of physiologically active substance |
| 02/16/2011 | CN101977627A Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 02/16/2011 | CN101977626A Use of serine protease inhibitors in the treatment of skin diseases |
| 02/16/2011 | CN101977625A Use of a substance for manufacturing of a medicament for treatment of common cold |
| 02/16/2011 | CN101977624A Preparation of a pharmaceutical composition for increasing bone mineral density |
| 02/16/2011 | CN101977623A Use of therapeutic peptides for the treatment and prevention of cancer |
| 02/16/2011 | CN101977622A Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network |
| 02/16/2011 | CN101977621A Fluorinated tripeptide hcv serine protease inhibitors |
| 02/16/2011 | CN101977620A Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 02/16/2011 | CN101977613A Synergistic 5'-methylthioadenosine combinations |
| 02/16/2011 | CN101974477A Escherichia coli expressing chicken alpha-interferon and application thereof |
| 02/16/2011 | CN101974395A Powerful antifatigue super oxide dismutase (SOD) health wine and preparation method thereof |
| 02/16/2011 | CN101974391A Wine with functions of resisting thrombosis, lowering blood lipid and expelling toxins and production method thereof |
| 02/16/2011 | CN101974090A GLP-1 analog fusion proteins |
| 02/16/2011 | CN101974089A Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection |
| 02/16/2011 | CN101974077A Novel polypeptide compound |
| 02/16/2011 | CN101974076A Cyclic peptide for inhibiting cell proliferation and blood vessel hyperplasia induced by basic fibroblast growth factors |
| 02/16/2011 | CN101974073A Anti-inflammatory hexapeptide |
| 02/16/2011 | CN101974069A High-efficiency binding peptide in DNA binding region protein of FoxM1c and method for acquiring polypeptide structure sequence |
| 02/16/2011 | CN101972481A Macromolecular microcarrier and preparation method thereof |
| 02/16/2011 | CN101972471A Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof |
| 02/16/2011 | CN101972470A In-situ gel composition for eyes |
| 02/16/2011 | CN101972469A Immune preparation for aquatic animals |
| 02/16/2011 | CN101972449A Chinese medicinal material earthworm enzyme and peptide compound preparation and preparation method thereof |
| 02/16/2011 | CN101972275A Gene treatment using TGF-beta secretion cell |
| 02/16/2011 | CN101972229A Preparation method of catalase solid lipid nanoparticles preparation |
| 02/16/2011 | CN101972224A Eye in-situ gel |
| 02/16/2011 | CN101361881B Preparation method as protein medicine lysozyme intestinal-tract sorbefacient |
| 02/16/2011 | CN101249262B Targeted nano granule of humanization monoclonal antibody trastuzumab modified packaged toxin protein, and preparation and applications thereof |
| 02/16/2011 | CN101099731B Use of erythropoietin |
| 02/15/2011 | USRE42150 Binding proteins for recognition of DNA |
| 02/15/2011 | US7888493 Nucleic acid encoding protein which has autoinducer inactivation activity; increase disease resistance in plants and animals; capable of efficient inactivation of N-acyl homoserine lactone autoinducers |
| 02/15/2011 | US7888490 Site-directed mutagenesis of the native genes of the toxin proteins, Protective Antigen, Lethal Factor and Edema Factor, using polymerase chain reaction; expression and purification |
| 02/15/2011 | US7888477 Isolated polynucleotide of ovarian tumor polypeptides, immunogenic portions, polynucleotides that encode polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 02/15/2011 | US7888469 Post-translation modification and clostridial neurotoxins |
| 02/15/2011 | US7888468 Recombinant copper containing protein for use in prevention and treatment of cell proliferative dsorders and infection |
| 02/15/2011 | US7888465 Methods for arbitrary peptide synthesis |